Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes
C-C.E. Lan
Departments of Dermatology, †Microbiology and ‡Pathology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan*Faculty of Biomedical Laboratory Science, College of Health Sciences, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
Search for more papers by this authorI-H. Liu
Departments of Dermatology, †Microbiology and ‡Pathology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan*Faculty of Biomedical Laboratory Science, College of Health Sciences, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
Search for more papers by this authorA-H. Fang
Departments of Dermatology, †Microbiology and ‡Pathology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan*Faculty of Biomedical Laboratory Science, College of Health Sciences, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
Search for more papers by this authorC-H. Wen
Departments of Dermatology, †Microbiology and ‡Pathology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan*Faculty of Biomedical Laboratory Science, College of Health Sciences, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
Search for more papers by this authorC-S. Wu
Departments of Dermatology, †Microbiology and ‡Pathology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan*Faculty of Biomedical Laboratory Science, College of Health Sciences, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
Search for more papers by this authorC-C.E. Lan
Departments of Dermatology, †Microbiology and ‡Pathology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan*Faculty of Biomedical Laboratory Science, College of Health Sciences, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
Search for more papers by this authorI-H. Liu
Departments of Dermatology, †Microbiology and ‡Pathology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan*Faculty of Biomedical Laboratory Science, College of Health Sciences, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
Search for more papers by this authorA-H. Fang
Departments of Dermatology, †Microbiology and ‡Pathology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan*Faculty of Biomedical Laboratory Science, College of Health Sciences, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
Search for more papers by this authorC-H. Wen
Departments of Dermatology, †Microbiology and ‡Pathology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan*Faculty of Biomedical Laboratory Science, College of Health Sciences, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
Search for more papers by this authorC-S. Wu
Departments of Dermatology, †Microbiology and ‡Pathology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan*Faculty of Biomedical Laboratory Science, College of Health Sciences, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
Search for more papers by this authorConflicts of interestNone declared.
Summary
Background Elevated blood glucose in patients with diabetes mellitus (DM) leads to complications including poor wound healing. Proper keratinocyte migration and proliferation are the crucial steps during re-epithelialization. We hypothesize that the impaired wound healing in patients with DM is due to the disruption of proper re-epithelialization.
Objectives We aimed to explore the effects of high glucose on keratinocytes in terms of cell migration and proliferation.
Methods Keratinocytes were cultivated in normal and high glucose conditions. Their viability was evaluated by MTS assay. Transwell migration and in vitro scratch assays were used to evaluate their mobility. The mRNA expressions and activities of matrix metalloproteinase (MMP)-2 and MMP-9 were determined. The mRNA of their respective physiological inhibitors, tissue inhibitor of MMP (TIMP)-1 and TIMP-2, was also evaluated. Immunofluorescent staining and Western blotting were used to examine the expression of phosphorylated focal adhesion kinase (pp125FAK). The impacts of high glucose on keratinocyte proliferation were assessed by 5-bromo-2′-deoxyuridine incorporation assay.
Results High glucose treatment did not affect keratinocyte viability up to 3 days. In contrast, the mobility of keratinocytes, the activities and gene expressions of MMP-2 and MMP-9, the expression of pp125FAK, and the cell proliferation after 5 days were significantly downregulated after hyperglycaemic treatments while the mRNA expression of TIMP-1 increased.
Conclusions Under hyperglycaemic conditions, keratinocytes demonstrate reduced migration and decreased proliferation capacities. These impairments of keratinocyte functions are likely to result in inadequate re-epithelialization. These defective physiological events provide a reasonable explanation for the poor wound healing commonly observed in patients with DM.
References
- 1 Wertheimer E, Spravchikov N, Trebicz M et al. The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes. Endocrinology 2001; 142: 1234–41.
- 2 Goodson WH, Hunt TK. Studies of wound healing in experimental diabetes mellitus. J Surg Res 1997; 22: 221–7.
- 3 Neil HA, Thompson AV, Thorogood M et al. Diabetes in the elderly: the Oxford Community Diabetes Study. Diabet Med 1989; 6: 608–13.
- 4 Greenhalgh DG. Wound healing and diabetes mellitus. Clin Plast Surg 2003; 30: 37–45.
- 5 Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ. Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 1997; 29: 5–17.
- 6 Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738–46.
- 7 Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005; 366: 1736–43.
- 8 Woodley DT, Chen JD, Kim JP et al. Re-epithelialization. Human keratinocyte locomotion. Dermatol Clin 1993; 11: 641–6.
- 9 Yates S, Rayner TE. Transcription factor activation in response to cutaneous injury: role of AP-1 in reepithelialization. Wound Repair Regen 2002; 10: 5–15.
- 10 Salonurmi T, Parikka M, Kontusaari S et al. Overexpression of TIMP-1 under the MMP-9 promoter interferes with wound healing in transgenic mice. Cell Tissue Res 2004; 315: 27–37.
- 11 Santoro MM, Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res 2005; 10: 274–86.
- 12 Saarialho-Kere UK, Kovacs SO, Pentland AP et al. Cell–matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 1993; 92: 2858–66.
- 13 Bullock AJ, Barker AT, Coulton L, MacNeil S. The effect of induced biphasic pulsed currents on re-epithelialization of a novel wound healing model. Bioelectromagnetics 2007; 28: 31–41.
- 14 Steffensen B, Hakkinen L, Larjava H. Proteolytic events of wound-healing-coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Crit Rev Oral Biol Med 2001; 12: 373–98.
- 15 Sivamani RK, Garcia MS, Isseroff RR. Wound re-epithelialization: modulating keratinocyte migration in wound healing. Front Biosci 2007; 1: 2849–68.
- 16 Fini ME, Girard MT, Matsubara M. Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmol Suppl 1992; 202: 26–33.
- 17 Legrand C, Gilles C, Zahm JM et al. Airway epithelial cell migration dynamics. MMP-9 role in cell–extracellular matrix remodeling. J Cell Biol 1999; 146: 517–29.
- 18 Ågren MS, Mirastschijski U, Karlsmark T et al. Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Exp Dermatol 2001; 10: 337–48.
- 19 Mirastschijski U, Impola U, Jahkola T et al. Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds. Hum Pathol 2002; 33: 355–64.
- 20 Mirastschijski U, Bugdahl R, Rollman O et al. Epithelial regeneration from bioengineered skin explants in culture. Br J Dermatol 2006; 154: 42–9.
- 21 Salo T, Makela M, Kylmaniemi M et al. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 1994; 70: 176–82.
- 22 Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995; 7: 728–35.
- 23 Lobmann R, Zemlin C, Motzkau M et al. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications 2006; 20: 329–35.
- 24 Varelias A, Cowin AJ, Adams D et al. Mitogenic bovine whey extract modulates matrix metalloproteinase-2, -9, and tissue inhibitor of matrix metalloproteinase-2 levels in chronic leg ulcers. Wound Repair Regen 2006; 14: 28–37.
- 25 Hanks SK, Polte TR. Signaling through focal adhesion kinase. Bioessays 1997; 19: 137–45.
- 26 Bockholt SM, Burridge K. Cell spreading on extracellular matrix proteins induces tyrosine phosphorylation of tensin. J Biol Chem 1993; 268: 14565–7.
- 27 Akasaka T, Van Leeuwen RL, Yoshinaga IG et al. Focal adhesion kinase (p125FAK) expression correlates with mobility of human melanoma cell lines. J Invest Dermatol 1995; 105: 104–8.
- 28 Rodina A, Schramm K, Musatkina E et al. Phosphorylation of p125FAK and paxillin focal adhesion proteins in src-transformed cells with different metastatic capacity. FEBS Lett 1999; 455: 145–8.
- 29 Spravchikov N, Sizyakov G, Gartsbein M et al. Glucose effects on skin keratinocytes: implications for diabetes skin complications. Diabetes 2001; 50: 1627–35.
- 30 Yu HS, Kao CH, Yu CL. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo. J Invest Dermatol 1993; 100: 823–8.
- 31 Thomas K, Kiwit M, Kerner W. Glucose concentration in human subcutaneous adipose tissue: comparison between forearm and abdomen. Exp Clin Endocrinol Diabetes 1998; 106: 465–9.
- 32 Park CW, Kim JH, Lee JH et al. High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is keratinocyte–NF-kappa B-dependent. Diabetologia 2000; 43: 1544–53.
- 33 Nakai K, Kubota Y, Kosaka H. Inhibition of nuclear factor kappa B activation and inducible nitric oxide synthase transcription by prolonged exposure to high glucose in the human keratinocyte cell line HaCaT. Br J Dermatol 2004; 150: 640–6.
- 34 Scudiero DA, Shoemaker RH, Paull KD. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988; 48: 4827–33.
- 35 Pilcher BK, Sudbeck BD, Dumin JA et al. Collagenase-1 and collagen in epidermal repair. Arch Dermatol Res 1998; 290: S37–46.
- 36 Liu LY, Hoffman GE, Fei XW et al. Delayed rectifier outward K+ current mediates the migration of rat cerebellar granule cells stimulated by melatonin. J Neurochem 2007; 102: 333–44.
- 37 Cha D, O’Brien P, O’Toole EA et al. Enhanced modulation of keratinocyte mobility by transforming growth factor-α (TGF-α) relative to epidermal growth factor (EGF). J Invest Dermatol 1996; 106: 590–7.
- 38 Woessner JF. Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol 1995; 248: 510–28.
- 39 Xu KP, Riggs A, Ding Y, Yu FS. Role of ErbB2 in corneal epithelial wound healing. Invest Ophthalmol Vis Sci 2004; 45: 4277–83.
- 40 Blakytny R, Jude E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 2006; 23: 594–608.
- 41 Marston WA. Risk factors associated with healing chronic diabetic foot ulcers: the importance of hyperglycemia. Ostomy Wound Manage 2006; 52: 26–8.
- 42 Grant MB, Guay C. Plasminogen activator production by human retinal endothelial cells of nondiabetic and diabetic origin. Invest Ophthalmol Vis Sci 1991; 32: 53–64.
- 43 Eshraghi S, Gotlieb AI. Insulin does not disrupt actin microfilaments, microtubules, and in vitro aortic endothelial wound repair. Biochem Cell Biol 1995; 73: 507–14.
- 44 Kampfer H, Pfeilschifter J, Frank S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 2001; 81: 361–73.
- 45 Hamuro M, Polan J, Natarajan M, Mohan S. High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis 2002; 162: 277–87.
- 46 Jialal I, Devaraj S, Venugopal SK. Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy. Free Radic Res 2002; 36: 1331–6.
- 47 Guzik TJ, West NE, Pillai R et al. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension 2002; 39: 1088–94.
- 48 Sivan-Loukianova E, Awad OA, Stepanovic V et al. CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res 2003; 40: 368–77.
- 49 Li W, Henry G, Fan J et al. Signals that initiate, augment, and provide directionality for human keratinocyte mobility. J Invest Dermatol 2004; 123: 622–33.
- 50 Choma DP, Pumiglia K, DiPersio CM. Integrin alpha3beta1 directs the stabilization of a polarized lamellipodium in epithelial cells through activation of Rac1. J Cell Sci 2004; 117: 3947–59.
- 51 Eliceiri BP. Integrin and growth factor receptor crosstalk. Circ Res 2001; 89: 1104–10.
- 52 Schwartz MA, Ginsberg MH. Networks and crosstalk: integrin signalling spreads. Nat Cell Biol 2002; 4: E65–8.
- 53 Li W, Fan J, Chen M, Woodley DT. Mechanisms of human skin cell mobility. Histol Histopathol 2004; 19: 1311–24.
- 54 Woodley DT. Re-epithelialization. In: The Molecular and Cellular Biology of Wound Repair ( RAF Clark, ed.), 2nd edn, New York: Plenum Publishing Corp., 1996; 339–50.
- 55 Ågren MS. Matrix metalloproteinases (MMPs) are required for re-epithelialization of cutaneous wounds. Arch Dermatol Res 1999; 291: 583–90.
- 56 Mignatti P, Rifkin DB. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 1996; 49: 117–37.
- 57 O’Toole EA. Extracellular matrix and keratinocyte migration. Clin Exp Dermatol 2001; 26: 525–30.
- 58 Chebassier N, El Houssein O, Viegas I, Dreno B. In vitro induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in keratinocytes by boron and manganese. Exp Dermatol 2004; 13: 484–90.
- 59 Mirastschijski U, Haaksma CJ, Tomasek JJ, Ågren MS. Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp Cell Res 2004; 299: 465–75.
- 60 Sawicki G, Marcoux Y, Sarkhosh K et al. Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors. Mol Cell Biochem 2005; 269: 209–16.
- 61 Mäkelä M, Larjava H, Pirila E et al. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Exp Cell Res 1999; 251: 67–78.
- 62 Munaut C, Salonurmi T, Kontusaari S et al. Murine matrix metalloproteinase 9 gene. 5′-upstream region contains cis-acting elements for expression in osteoclasts and migrating keratinocytes in transgenic mice. J Biol Chem 1999; 274: 5588–96.
- 63 Soo C, Shaw WW, Zhang X et al. Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. Plast Reconstr Surg 2000; 105: 638–47.
- 64 Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 1995; 270: 5872–6.
- 65 Corcoran ML, Hewitt RE, Kleiner DE Jr, Stetler-Stevenson WG. MMP-2: expression, activation and inhibition. Enzyme Protein 1996; 49: 7–19.
- 66 Bigg HF, Rowan AD, Barker MD, Cawston TE. Activity of matrix metalloproteinase-9 against native collagen types I and III. FEBS J 2007; 274: 1246–55.
- 67 Sarret Y, Woodley DT, Goldberg GS et al. Constitutive synthesis of a 92-kDa keratinocyte-derived type IV collagenase is enhanced by type I collagen and decreased by type IV collagen matrices. J Invest Dermatol 1992; 99: 836–41.
- 68 Leco KJ, Khokha R, Pavloff N et al. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994; 269: 9352–60.
- 69 Leco KJ, Apte SS, Taniguchi GT et al. Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett 1997; 401: 213–17.
- 70 Shankland SJ, Ly H, Thai K, Scholey JW. Glomerular expression of tissue inhibitor of metalloproteinase (TIMP-1) in normal and diabetic rats. J Am Soc Nephrol 1996; 7: 97–104.
- 71 Madlener M. Differential expression of matrix metalloproteinases and their physiological inhibitors in acute murine skin wounds. Arch Dermatol Res 1998; 290: S24–9.
- 72 Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000; 1477: 267–83.
- 73 Sugita Y, Morita E, Tanaka T et al. Production of tissue inhibitor of metalloproteinase-1 and -2 by cultured keratinocytes. J Dermatol Sci 2000; 22: 107–16.
- 74 Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol 1999; 30: 795–802.
- 75 Lee OH, Bae SK, Bae MH et al. Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models. Br J Cancer 2000; 82: 385–91.
- 76 Coletta RD, Almeida OP, Reynolds MA, Sauk JJ. Alteration in expression of MMP-1 and MMP-2 but not TIMP-1 and TIMP-2 in hereditary gingival fibromatosis is mediated by TGF-beta 1 autocrine stimulation. J Periodontal Res 1999; 34: 457–63.
- 77 Singh R, Song RH, Alavi N et al. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1. Exp Nephrol 2001; 9: 249–57.
- 78 Han SY, Jee YH, Han KH et al. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy. Nephrol Dial Transplant 2006; 21: 2406–16.
- 79 Wilson MJ, Sellers RG, Wiehr C et al. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. J Cell Physiol 2002; 191: 208–16.
- 80 Hanks SK, Calalb MB, Harper MC, Patel SK. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA 1992; 89: 8487–91.
- 81 Schaller MD, Borgman CA, Cobb BS et al. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions Proc Natl Acad Sci USA 1992; 89: 5192–6.
- 82 Romer J, Lund LR, Eriksen J et al. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. J Invest Dermatol 1994; 102: 519–22.
- 83 Gates RE, King LE, Hanks SK, Nanney LB. Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture. Cell Growth Differ 1994; 5: 891–9.
- 84 Owens LV, Xu L, Craven RJ et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 1995; 55: 2752–5.
- 85 Cary LA, Chang JF, Guan JL. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 1996; 109: 1787–94.
- 86 Kim LT, Wu J, Bier-Laning C et al. Focal adhesion kinase up-regulation and signaling in activated keratinocytes. J Surg Res 2000; 91: 65–9.
- 87 Yurko MA, O’Toole EA, Woodley DT. Phosphorylation of focal adhesion kinase (pp125(FAK)) is increased in human keratinocytes induced to migrate by extracellular matrices. J Cell Physiol 2001; 188: 24–32.
- 88 Garlick JA, Taichman LB. Fate of human keratinocytes during reepithelialization in an organotypic culture model. Lab Invest 1994; 70: 916–24.
- 89 Martin P. Wound healing – aiming for perfect skin regeneration. Science 1997; 276: 75–81.
- 90 Avena R, Mitchell ME, Carmody B et al. Insulin-like growth factor-1 receptors mediate infragenicular vascular smooth muscle cell proliferation in response to glucose and insulin not by insulin receptors. Am J Surg 1999; 178: 156–61.
- 91 Han DC, Isono M, Hoffman BB, Ziyadeh FN. High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. J Am Soc Nephrol 1999; 10: 1891–9.
- 92 McDermott AM, Kern TS, Murphy CJ. The effect of elevated extracellular glucose on migration, adhesion and proliferation of SV40 transformed human corneal epithelial cells. Curr Eye Res 1998; 17: 924–32.
- 93 Hehenberger K, Heilborn JD, Brismar K, Hansson A. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate. Wound Repair Regen 1998; 6: 135–41.
- 94 Nahman NS Jr, Leonhart KL, Cosio FG, Hebert CL. Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int 1992; 41: 396–402.
- 95 Nakao-Hayashi J, Ito H, Kawashima S. An oxidative mechanism is involved in high glucose-induced serum protein modification causing inhibition of endothelial cell proliferation. Atherosclerosis 1992; 97: 89–95.
- 96 Jiaojun D, Takami Y, Tanaka H et al. Protective effects of a free radical scavenger, MCI-186, on high glucose-induced dysfunction of human dermal microvascular endothelial cells. Wound Repair Regen 2004; 12: 607–12.
- 97 Terashi H, Izumi K, Deveci M et al. High glucose inhibits human epidermal keratinocyte proliferation for cellular studies on diabetes mellitus. Int Wound J 2005; 2: 298–304.
